|
|
Volumn 283, Issue 9, 2000, Pages 1125-
|
|
AIDS researchers explore new drug options
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE);
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
CHEMOKINE RECEPTOR CCR5;
CHEMOKINE RECEPTOR CXCR4;
ENFUVIRTIDE;
NEW DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
DRUG POTENCY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFLAMMATION;
INJECTION SITE;
MEDICAL RESEARCH;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
T LYMPHOCYTE SUBPOPULATION;
VIRUS CELL INTERACTION;
VIRUS LOAD;
|
|
EID: 0034161624
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.283.9.1125 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|